Document is current
Any future updates will be listed below
-
Authors
Matt, Rachel A. https://orcid.org/0000-0002-9944-8897
Martin, Renee S. https://orcid.org/0000-0002-3975-1480
Evans, Andrew K. https://orcid.org/0000-0003-2986-6476
Gever, Joel R. https://orcid.org/0000-0001-9968-2299
Vargas, Gabriel A. https://orcid.org/0000-0001-8511-6042
Shamloo, Mehrdad https://orcid.org/0000-0003-4404-1755
Ford, Anthony P. https://orcid.org/0000-0001-8618-0273
- License Information
-
More Information
Chapter History
First Online: 27 July 2023
Funding Sources/Conflict of Interest
: AF and MS are co-founders of CuraSen Therapeutics, a company developing adrenergic drugs for the treatment of neurodegenerative disease. All authors own shares of stock in CuraSen Therapeutics. Some of the work presented here was partially supported by the National Institutes of Health (NIH R01 AG054533) awarded to MS.
